Benzinga's Top Upgrades - Align Tech (NASDAQ:ALGN), Bristol-Myers Squibb (NYSE:BMY)

Analysts at Keefe Bruyette & Woods upgraded

Square 1 Financial IncSQBK

from Market Perform to Outperform. The price target for Square 1 Financial has been raised from $26.00 to $32.00. Square 1 Financial shares closed at $25.97 yesterday. JP Morgan upgraded

Paychex, Inc.PAYX

from Underweight to Neutral. The price target for Paychex has been raised from $43.00 to $48.00. Paychex shares closed at $48.98 yesterday. Analysts at FBR Capital upgraded

First Horizon National CorpFHN

from Underperform to Market Perform. The price target for First Horizon National is set to $14. First Horizon National shares closed at $14.37 yesterday. Analysts at Stifel Nicolaus upgraded

First Industrial Realty Trust, Inc.FR

from Hold to Buy. The price target for First Industrial Realty is set to $22. First Industrial Realty shares closed at $20.36 yesterday. Bank of America upgraded

Crown Holdings, Inc.

CCK

from Neutral to Buy. Crown Holdings' shares closed at $55.43 yesterday. Analysts at Argus Research upgraded

Check Point Software Technologies Ltd.CHKP

from Hold to Buy. Check Point Software shares closed at $85.88 yesterday. Credit Suisse upgraded

Total SA (ADR)TOT

from Neutral to Outperform. Total shares closed at $52.62 yesterday. Morgan Stanley upgraded

Align Technology, Inc.ALGN

from Equal-weight to Overweight. The price target for Align Technology has been raised from $56.00 to $79.00. Align Technology shares closed at $54.21 yesterday. Morgan Stanley upgraded

Bristol-Myers Squibb CoBMY

from Equal-weight to Overweight. The price target for Bristol-Myers Squibb has been raised from $60.00 to $80.00. Bristol-Myers Squibb shares closed at $65.86 yesterday.

Market News and Data brought to you by Benzinga APIs